The pharmaceutical industry is facing unprecedented growth and disruption, with challenges such as globalization, changing consumer demand, and integration pains from mergers and acquisitions. The industry is highly regulated, with drug approval and market access requiring navigation of multiple jurisdictions. The increasing complexity in the operating environment is the top challenge for the industry, requiring pharmaceutical companies to meet strategic priorities while containing costs and driving growth. Reliance on contract manufacturing organizations and M&As have increased production capabilities and fueled growth, but also brought significant integration challenges.
